Research & Development
Siemens Healthineers Receives FDA Emergency Use Authorization for its SARS-CoV-2 Total Antibody Test
2 June 2020 - - The US Food and Drug Administration has issued an Emergency Use Authorization for German technology company Siemens' (OTC: SIEGY) Siemens Healthineers' laboratory-based total...
Eisai unveils DAYVIGO (lemborexant) CIV for the US insomnia market
2 June 2020 - Pharmaceutical company Eisai Inc reported on Monday the launch of the US FDA approved DAYVIGO (lemborexant) CIV for the treatment of adults with insomnia, characterised by difficulties w...
3NT Medical receives FDA clearance for the Colibri endoscopy system designed for otologists
2 June 2020 - Israeli medical device company 3NT Medical reported on Monday the receipt of US FDA 510(k) clearance to market the Colibri Micro ENT Scope endoscope specifically designed for otology.The...
Camurus files request for final approval of Brixadi with the FDA for the treatment of opioid use disorder
2 June 2020 - Swedish biopharmaceutical company Camurus AB (NASDAQ:CAMX) (STO:CAMX) announced on Monday that it has filed a request for final approval of Brixadi (buprenorphine) with the US Food and D...
Sema4 to Deliver High Capacity COVID-19 Testing in Partnership with the State of Connecticut
1 June 2020 - - US-based health intelligence company Sema4 has inked a formal partnership with the State of Connecticut to be a COVID-19 testing provider for Connecticut residents, the company said.
FDA Accepts Shionogi's Supplemental New Drug Application with Priority Review for Fetroja for the Treatment of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
1 June 2020 - - The US Food and Drug Administration has accepted Japan-based Shionogi and Co's supplemental New Drug Application for Fetroja (cefiderocol) and granted Priority Review designation ...
Related Headlines

Apollo Hospitals Group Integrates Zebra Medical Vision's AI for COVID-19 Detection and Disease Progression Tracking

US FDA grants approval to Menlo Therapeutics' ZILXI topical foam, 1.5%

Acupath Laboratories launches COVID-19 testing using ThermoFisher TaqPath RT-PCR COVID-19 Combo kit

Acupath introduces COVID19 testing in NY and beyond for all three coronavirus genes

LetsGetChecked Launches FDA EUA-Authorised At-Home Coronavirus (COVID-19) Sure-track Test

Beckman Coulter Life Sciences' RNA extraction kit ready for use in EUA authorized COVID-19 test

Quest Diagnostics wins FDA's EUA for COVID-19 nasal specimen self-collection kit

Partner Therapeutics to evaluate Leukine in respiratory illness in patients with COVID-19 at Singapore General Hospital

Genentech Starts Phase III Clinical Trial of Actemra Plus Remdesivir in Hospitalized Patients with Severe COVID-19 Pneumonia

StemExpress Expands offering of COVID-19 Testing to Skilled Nursing Facilities

PureTech Advances LYT-100 for Treatment of Serious Respiratory Complications that Persist Following Resolution of COVID-19 Infection

ImmunityBio, NantKwest Ink COVID-19 Joint Development, Manufacturing and Marketing Agreement

Ajinomoto Bio-Pharma Services partners with Aji Bio-Pharma for supply of lenzilumab for COVID-19 study

FDA reports availability of new tool to help develop and evaluate diagnostic tests for SARS-CoV-2 infection

Oncopeptides restarts patient enrolment for melflufen clinical programme following temporary pause due to COVID-19